DoW Neurofibromatosis Investigator-Initiated Research Award

The summary for the DoW Neurofibromatosis Investigator-Initiated Research Award grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Defense Health Agency Contracting Activity - DHACA, which is the U.S. government agency offering this grant.
DoW Neurofibromatosis Investigator-Initiated Research Award: Summary: The fiscal year 2026 (FY26) Neurofibromatosis Research Program (NFRP) Investigator-Initiated Research Award (IIRA) supports high-impact research that addresses a critical need and has the potential to make important contributions to the field of neurofibromatosis disorders or advance patient care. Research projects may focus on any phase of research, excluding clinical trials. The rationale for a research idea may be derived from laboratory discovery, population-based studies, a clinician’s firsthand knowledge of patients, or anecdotal data. Applications must include preliminary and/or published data that are relevant to NF and the proposed research project.Distinctive Features: This award mechanism offers two funding levels based on participation in two optional features:• Open Science Initiative: Catalyzes research for neurofibromatosis through early access to data and data sharing within the neurofibromatosis community.• Optional Qualified Collaborator: Encourages collaborative research between basic scientists and clinical researchers, and between academic and biotechnology scientists.The funding levels are defined as follows:• Level 1: Applications without an optional feature.• Level 2: Applications including one of the optional features.
Federal Grant Title: DoW Neurofibromatosis Investigator-Initiated Research Award
Federal Agency Name: Defense Health Agency Contracting Activity - DHACA (DOD-AMRAA)
Grant Categories: Science and Technology and other Research and Development
Type of Opportunity: Discretionary
Funding Opportunity Number: HT942526NFRPIIRA
Type of Funding: Grant
CFDA Numbers: 12.420
CFDA Descriptions: Information not provided
Current Application Deadline: September 22nd, 2026
Original Application Deadline: September 22nd, 2026
Posted Date: June 25th, 2026
Creation Date: June 25th, 2026
Archive Date: October 22nd, 2026
Total Program Funding: $6,040,000
Maximum Federal Grant Award:
Minimum Federal Grant Award:
Expected Number of Awards: 7
Cost Sharing or Matching: No
Last Updated: June 25th, 2026
Applicants Eligible for this Grant
Unrestricted (i.e., open to any type of entity below), subject to any clarification in text field entitled "Additional Information on Eligibility"
Grant Announcement Contact
eBRAP Help Desk
Phone: 301-682-5507
Email: [email protected]
eBRAP Help Desk
Similar Government Grants
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DoW Neurofibromatosis Research Academy - Scholar Award
DoW Neurofibromatosis Synergistic Idea Award
DOW Combat Readiness - Medical Research Program Translational Research Award
DoW Neurofibromatosis Research Academy - Leadership Award
FY2006 Deployed War Fighter Protection Research Program
Department of Defense (DOD) Fiscal Year 2003 (FY03) Breast Cancer Research Program (BCRP)C...
Department of Defense (DOD) Fiscal Year 2004 (FY04) Breast Cancer Research Program (BCRP) ...
More Grants from the Defense Health Agency Contracting Activity - DHACA
DoW Neurofibromatosis Exploration-Hypothesis Development Award
DoW Neurofibromatosis Research Academy - Scholar Award
DoW Neurofibromatosis Synergistic Idea Award

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2026 FederalGrants.com